Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo
- 19 March 2004
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 25 (10) , 1283-1292
- https://doi.org/10.1016/j.neurobiolaging.2004.01.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- Nonsteroidal Anti-inflammatory Drugs and Alzheimer DiseaseJAMA, 2003
- Exploratory clinical testing of neuroscience drugsNature Neuroscience, 2002
- Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal ViabilityJournal of Biological Chemistry, 2002
- Hepatotoxicity of Commonly Used Drugs: Nonsteroidal Anti-Inflammatory Drugs, Antihypertensives, Antidiabetic Agents, Anticonvulsants, Lipid-Lowering Agents, Psychotropic DrugsSeminars in Liver Disease, 2002
- Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic MiceJournal of Neuroscience, 2002
- Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathologyNeurobiology of Aging, 2001
- Inflammation and Alzheimer's diseaseNeurobiology of Aging, 2000
- Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease ProgressionBrain Pathology, 1998
- Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid depositsNeurobiology of Aging, 1996